SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-004601
Filing Date
2022-02-14
Accepted
2022-02-14 20:48:25
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 13472
  Complete submission text file 0001493152-22-004601.txt   14904
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 269 S. BEVERLY DR. #1315 BEVERLY HILLS CA 90212
Business Address
Schwartzberg Gil (Reporting) CIK: 0001472409 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39717 | Film No.: 22636615